Health-related quality of life in cancer patients treated with immune checkpoint inhibitors: A systematic review on reporting of methods in randomized controlled trials

OBJECTIVE: Immune checkpoint inhibitors (ICIs) have recently shown tremendous promise in the treatment of diverse cancers. The available data suggests that ICIs are well tolerated in terms of health-related quality of life (HRQOL) compared to other anticancer therapies. However, it appears that inst...

Descripción completa

Detalles Bibliográficos
Autores principales: Faury, Stéphane, Foucaud, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980610/
https://www.ncbi.nlm.nih.gov/pubmed/31978145
http://dx.doi.org/10.1371/journal.pone.0227344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980610/
https://www.ncbi.nlm.nih.gov/pubmed/31978145
http://dx.doi.org/10.1371/journal.pone.0227344

Ejemplares similares